Catherine Stehman-Breen

Catherine Stehman-Breen serves as Chief Executive Officer at Tenaya Therapeutics. Tenaya Therapeutics operates in the research sector with approximately 130.0 employees. The company is headquartered in Cambridge, Massachusetts. Tenaya Therapeutics generates annual revenue of 4500000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 4 executives at Tenaya Therapeutics.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Mimecast Outlook Microsoft Office 365 Google Cloud Hosting Google Tag Manager YouTube Mobile Friendly Nginx Greenhouse.io Bootstrap Framework Vimeo Typekit WordPress.org Remote

cardiovascular disease heart failure gene therapy cardiomyopathies in vivo cellular reprogramming ipsccardiomyoctyes precision medicine cellular regeneration biotechnology: biological products (no diagnostic substances) health care biotechnology research cardiomyopathy heart disease aav vectors biotechnology clinical trials mybpc3 mutation pkp2 mutation gmp manufacturing therapeutic development regenerative medicine patient advocacy disease modeling in vivo models high-throughput screening capsid engineering drug delivery clinical efficacy cgmp drug product biopharmaceutical therapeutic payloads genetic diseases arrhythmogenic right ventricular cardiomyopathy hypertrophic cardiomyopathy fibrosis cardiac function novel therapies orphan drug designation human genetics drug discovery biomarkers genetic therapies small molecule inhibitors hdac6 inhibition dilated cardiomyopathy sarcoplasmic reticulum cardiac reprogramming clinical development therapeutic candidates regulatory pathways patient-centered care disease modification genetic testing diagnostic precision patient journeys collaborations biopharmaceutical leadership innovative therapies clinical-stage therapeutic platforms disease-modifying therapies myocardial infarction small molecule therapeutics patient populations healthcare providers advanced treatment options genetic disorders cardiovascular conditions research collaborations transformative treatments unmet medical needs healthcare sector biotechnology industry gene editing patient outcomes cardiovascular health clinical research participation advanced solutions healthcare institutions genetic medicine curative therapies health wellness & fitness hospital & health care

KK

Kee-Hong Kim Chief Technology Officer at Tenaya Therapeutics

FA

Faraz Ali Chief Executive Officer at Tenaya Therapeutics

SL

Shuai Li Chief Business Officer at Tenaya Therapeutics

How can I contact Catherine Stehman-Breen?

Catherine Stehman-Breen's verified email address is available on MessageCEO. They currently work at Tenaya Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Catherine Stehman-Breen lead?

Catherine Stehman-Breen is Chief Executive Officer at Tenaya Therapeutics, a company in the research sector with 130.0 employees. The company is based in Cambridge, Massachusetts.

What industry is Catherine Stehman-Breen in?

Catherine Stehman-Breen works in the research industry as Chief Executive Officer at Tenaya Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Catherine Stehman-Breen's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Catherine Stehman-Breen's profile is kept up-to-date with the latest available information.

Last updated: April 27, 2026